ReviewCurrent hypertension reports2019
Cost-Effectiveness and Challenges of Implementing Intensive Blood Pressure Goals and Team-Based Care.
Review in Current hypertension reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Lay advisor interventions for hypertension outcomes: A Systematic Review, Meta-analysis and a RE-AIM evaluation.Frontiers in medicine · 2024Pooled it
- Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial.JAMA network open · 2022Trial
- User-Centered Design Approach to Dynamic Clinical Decision Support in Primary Prevention of Cardiovascular Disease.Healthcare (Basel, Switzerland) · 2026Article
- Long-term cost-effectiveness of pharmacist-managed hypertension care in China.BMC health services research · 2025Article
- Patient engagement pilot for uncontrolled hypertension: implications for quality, safety, and population health.Frontiers in health services · 2025Article
- Medical Measures in Hypertensives Considered Resistant.American journal of hypertension · 2024Article
- Impact of COVID-19-related care disruptions on blood pressure management and control in community health centers.BMC public health · 2022Article
- Addressing Hypertension Outcomes Using Telehealth and Population Health Managers: Adaptations and Implementation Considerations.Current hypertension reports · 2022Review
- Cost-Effectiveness of Recommendations From the Surgeon General's Call-to-Action to Control Hypertension.American journal of hypertension · 2022Review
- Cost-effectiveness analysis of intensive blood pressure control in Korea.Hypertension research : official journal of the Japanese Society of Hypertension · 2022Article
- Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID-19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID-19 Pandemic.Journal of the American Heart Association · 2021Article
- Team-Based Care for Improving Hypertension Management: A Pragmatic Randomized Controlled Trial.Frontiers in cardiovascular medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purpose of reviewReview the effectiveness, cost-effectiveness, and implementation challenges of intensive blood pressure (BP) control and team-based care initiatives. RECENT
findingsIntensive BP control is an effective and cost-effective intervention; yet, implementation in routine clinical practice is challenging. Several models of team-based care for hypertension management have been shown to be more effective than usual care to control BP. Additional research is needed to determine the cost-effectiveness of team-based care models relative to one another and as they relate to implementing intensive BP goals. As a focus of healthcare shifts to value (i.e., cost, effectiveness, and patient preferences), formal cost-effectiveness analyses will inform which team-based initiatives hold the highest value in different healthcare settings with different populations and needs. Several challenges, including clinical inertia, financial investment, and billing restrictions for pharmacist-delivered services, will need to be addressed in order to improve public health through intensive BP control and team-based care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.